Schellenberg Wittmer advised Swisscanto Private Equity in the CHF 8.3 million Series B financing of the renowned innovator in ultrasonic camera technology Distran, an ETH Zürich spin-off. The funding will be deployed to fuel the
Tags :Alisa Zehner
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million